Novartis AG is 102.3x more valuable than SOLENO THERAPEUTICS INC by market capitalization ($282.64 B vs $2.76 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | SLNO | NVS |
|---|---|---|
| Market cap | $2.76 B | $282.64 B |
| US-listed rank | #1873 | #47 |
| Revenue (latest FY) | $190.41M | - |
| Net income (latest FY) | $20.89M | - |
| Net margin | 11.0% | - |
| P/E (trailing FY) | 132.3 | - |
| SEC filings | 1,119 | 947 |
Novartis AG is 102.3x more valuable than SOLENO THERAPEUTICS INC by market capitalization ($282.64 B vs $2.76 B).
Full pages: SOLENO THERAPEUTICS INC and Novartis AG, or browse the full rankings.